← Friday 23 Octobernote 6 of 14
Health researchFri 23 Oct 2026 · 6 of 14

Discrimination Linked to Mental‑Health Crisis Among U.S. LGBTQ+ Youth

Verified · 6/6 supported1 cited · 1 min read

Medical Xpress reports that discrimination fuels high rates of anxiety, depression and suicidal thoughts among LGBTQ+ youth in the United States . Medical Xpress reports that acceptance and access to care can reduce the risk of mental health problems and suicide for these young people . Medical Xpress reports that The Trevor Project says creating welcoming and supportive environments is a lifesaving intervention for LGBTQ+ youth . Medical Xpress reports that Project SPARK is a two‑year study following nearly 1,700 LGBTQ+ youth ages 13‑24, with surveys every six months since September 2023 . Medical Xpress reports that LGBTQ+ youth exposed to or threatened with conversion therapy have nearly three times higher risk of suicidal thoughts or behaviors, and those who are homeless or victimized because of gender identity have more than double that risk .

Why it matters. Medical Xpress notes that improving acceptance and providing supportive environments could significantly lower suicide risk for LGBTQ+ youth .

Earlier on Health research

Thu 22 Oct 2026Canada's under‑5s largely active and well‑rested, but screen‑time compliance lowMedical Xpress reports that 67% of Canadian children under age 5 met the physical activity recommendation. Medical Xpress reports that 80% of those children met the sleep recommendation. Medical Xpress reports that fewer than half—48%—met screen‑time limits. Medical Xpress reports that only 25% met all three recommendations for activity, sleep and screen time. Medical Xpress reports that the guidelines advise 12–17 hours of sleep for babies under 1 year, 11–14 hours for toddlers 1–2, and 10–13 hours for preschoolers 3–4, plus at least 30 minutes of tummy time for babies and a minimum of 180 minutes of daily physical activity for toddlers and preschoolers.Wed 21 Oct 2026Study links autoimmune rheumatic diseases to higher long COVID riskMedical Xpress reports that a retrospective cohort study by Namrata Singh, M.D., and colleagues, published online Oct 14 in Arthritis & Rheumatology, examined long COVID in patients with autoimmune rheumatic diseases (AIRD) using data from the National Clinical Cohort Collaborative. Medical Xpress reports that the study found AIRD patients have an increased risk for long COVID compared with non‑AIRD controls. Medical Xpress reports that higher acute COVID‑19 severity, pulmonary disease, obesity, and exposure to rituximab or glucocorticoids were linked to greater long COVID risk among AIRD patients. Medical Xpress reports that Sjögren syndrome was associated with a higher risk of long COVID in the AIRD cohort.Wed 21 Oct 2026FDA approves Hibsago, first antisense drug for chronic hepatitis BThe U.S. Food and Drug Administration approved Hibsago (bepirovirsen) injection, to be used with existing antiviral therapy, for treating chronic hepatitis B virus infection in certain adults without cirrhosis. Hibsago is the first FDA‑approved antisense oligonucleotide for chronic hepatitis B. Approval is limited to adults without cirrhosis who have been on HBV antiviral therapy for at least six months, have suppressed HBV levels, and have hepatitis B surface antigen levels of 3,000 IU/mL or less, as measured by an FDA‑authorized test. The treatment is intended to give some patients the possibility of maintaining control of the virus after completing chronic HBV therapy.
Next · Film and TVJeff Garlin says three-year work on WALL‑E permanently damaged his voice →